000 | 01867 a2200541 4500 | ||
---|---|---|---|
005 | 20250517084203.0 | ||
264 | 0 | _c20170606 | |
008 | 201706s 0 0 eng d | ||
022 | _a1346-8138 | ||
024 | 7 |
_a10.1111/1346-8138.13340 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHigashiyama, Ayaka | |
245 | 0 | 0 |
_aFlutamide-induced photoleukomelanoderma. _h[electronic resource] |
260 |
_bThe Journal of dermatology _cSep 2016 |
||
300 |
_a1105-6 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAndrogen Antagonists _xadverse effects |
650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aBiphenyl Compounds _xtherapeutic use |
650 | 0 | 4 |
_aBisoprolol _xtherapeutic use |
650 | 0 | 4 | _aClopidogrel |
650 | 0 | 4 |
_aDrug Eruptions _xdiagnosis |
650 | 0 | 4 |
_aEicosapentaenoic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aEzetimibe _xtherapeutic use |
650 | 0 | 4 |
_aFlutamide _xadverse effects |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPatch Tests |
650 | 0 | 4 |
_aPhotosensitivity Disorders _xchemically induced |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aSkin Pigmentation _xdrug effects |
650 | 0 | 4 |
_aSunlight _xadverse effects |
650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
650 | 0 | 4 |
_aUrsodeoxycholic Acid _xtherapeutic use |
650 | 0 | 4 | _aWithholding Treatment |
700 | 1 | _aYokoyama, Tomoya | |
700 | 1 | _aOmoto, Yoichi | |
700 | 1 | _aHabe, Koji | |
700 | 1 | _aYamanaka, Keiichi | |
700 | 1 | _aMizutani, Hitoshi | |
773 | 0 |
_tThe Journal of dermatology _gvol. 43 _gno. 9 _gp. 1105-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/1346-8138.13340 _zAvailable from publisher's website |
999 |
_c25821439 _d25821439 |